caffeic acid phenethyl ester has been researched along with Disease Models, Animal in 77 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.30) | 18.2507 |
| 2000's | 24 (31.17) | 29.6817 |
| 2010's | 46 (59.74) | 24.3611 |
| 2020's | 6 (7.79) | 2.80 |
| Authors | Studies |
|---|---|
| Abbott, BM; Browne, EC | 1 |
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Gur, C; Ileriturk, M; Kandemir, FM; Kaynar, O; Semis, HS | 1 |
| He, W; Huang, Y; Li, M; Li, W; Luo, Y; Mei, Y; Pan, H; Wan, T; Wang, Q; Wang, Z; Xue, J; Zhang, Y | 1 |
| Aksu Kızıldağ, C; Albayrak, M; Arabacı, T; Balseven, HM; Kızıldağ, A; Tasdemir, U | 1 |
| Akcay, E; Palaz, MN | 1 |
| Cantürk Tan, F; Ceylan, T; Kaymak, E; Yakan, B | 1 |
| Cao, Y; Du, Q; Jiang, Y; Jiao, X; Li, Y; Liu, X; Tang, M; Tian, C; Wang, Y; Wang, Z; Xie, P; Yang, J | 1 |
| Dokuyucu, R; Gökçe, H; Gülmez, Mİ; Okuyucu, Ş | 1 |
| Chen, S; Deng, W; Li, J; Liao, H; Ren, J; Tang, Q; Xu, L; Yang, Z; Zhang, N | 1 |
| Kırzıoğlu, FY; Nazıroğlu, M; Özmen, Ö; Uğuz, AC; Yiğit, U | 1 |
| Khan, MN; Lane, ME; McCarron, PA; Tambuwala, MM | 1 |
| Deveci, HA; Karapehlivan, M | 1 |
| Hang, C; Liao, K; Sun, L | 1 |
| Balkhi, HM; Gul, T; Haq, E; Sana, S | 1 |
| Dos Santos, JS; Monte-Alto-Costa, A; Romana-Souza, B | 1 |
| Dhammu, TS; Khan, H; Khan, M; Shunmugavel, A; Singh, AK; Singh, I | 1 |
| Kesharwani, P; McCarron, PA; Shukla, R; Tambuwala, MM; Thompson, PD | 1 |
| Khan, MN; McCarron, PA; Tambuwala, MM; Thompson, P | 1 |
| Cheng, CC; Chi, PL; Huang, WC; Liu, CP; Shen, MC; Shu, CW; Tseng, CJ; Wann, SR | 1 |
| Chen, C; Huang, L; Jia, Y; Jiang, S; Lu, G; Sun, X; Xie, Y | 1 |
| Akdemir, F; Evliyaoglu, O; Evsen, MS; Ozler, A; Sak, ME; Soydinc, HE; Turgut, A; Turkcu, G | 1 |
| Bai, H; Chen, H; Hai, C; Li, W; Liang, X; Liu, R; Qin, X; Wang, X; Zhang, W; Zhang, X | 1 |
| Hong, S; Jung, Y; Kim, H; Kim, W; Kwak, MK; Lee, JW; Na, DH; Oh, JE; Park, EJ; Yum, S | 1 |
| Bayram, E; Karakaya, P; Kurul, SH; Özbal, S; Topçu, Y; Tuğyan, K; Yilmaz, O; Yiş, U | 1 |
| Aşçı, M; Bostan, B; Erdem, M; Gülabi, D; Güneş, T; Köseoğlu, RD | 1 |
| İlhan, S; Motor, S; Nacar, E; Oktar, S; Şahna, E; Yılmaz, N | 1 |
| Akyol, O; Akyol, S; Balci, M; Cakmak, O; Erden, G; Gurel, A; Ugurcu, V | 1 |
| Bae, ON; Bae, S; Kim, ES; Koo, JE; Lee, JY; Lim, KM | 1 |
| Choi, JH; Ha, SM; Jung, SY; Kang, MS; Lee, JH; Oh, H; Park, S; Park, SJ; Roh, KH; Song, H; Yang, JW | 1 |
| Cantley, MD; Crotti, TN; Dharmapatni, AA; Gibson, RJ; Haynes, DR; Marino, V; Perilli, E; Stansborough, RL; Xu, J; Zawawi, MS | 1 |
| Alici, O; Alici, S; Altintas, ND; Aydin, M; Kavakli, HS; Koca, C | 1 |
| Alp, H; Evliyaoglu, O; Firat, U; Gelincik, I; Kapan, M; Onder, A; Senol, S; Tekin, R; Tokgoz, O | 1 |
| Guo, L; Li, Y; Shi, L; Shi, Y; Song, M; Yu, J | 1 |
| Baykal, B; Elbey, B; Keskin, I; Kuş, S; Şahin, A; Yazgan, ÜC; Yılmaz, A | 1 |
| Acquaviva, R; Di Giacomo, C; Pittalà, V; Romeo, G; Salerno, L; Sorrenti, V | 1 |
| Choi, JY; Jeong, S; Jung, Y; Kim, ND; Lee, HE; Lee, JY; Park, HH; Yang, G | 1 |
| Abdullah, HI; Durdagi, S; Duruyurek, M; Ekhteiari Salmas, R; Gulhan, MF; Selamoglu, Z | 1 |
| Hennig, B; MacDonald, R; Oesterling, E; Shen, H; Stromberg, A; Toborek, M | 1 |
| Ciçek, E; Gökalp, O; Ozçelik, N; Ozer, MK; Uz, E; Yilmaz, HR | 1 |
| Bagci, C; Bilgic, T; Buyukberber, M; Ceylan, NO; Gulsen, MT; Koruk, M; Savaş, MC; Tutar, E | 1 |
| Aydin, M; Davarci, M; Gökçe, A; Ilhan, S; Oktar, S; Ozkan, OV; Yalçinkaya, FR; Yönden, Z | 1 |
| Ateş, B; Erdoğan, A; Eşrefoğlu, M; Gül, M | 1 |
| Gomonchareonsiri, S; Thamprasert, K; Wongmekiat, O | 1 |
| Andiran, F; Haltas, H; Hirfanoglu, IM; Kosus, A; Tatli, MM; Tayman, C; Tonbul, A; Uysal, S | 1 |
| Dash, PK; Moore, AN; Pati, S; Redell, JB; Zhang, M; Zhao, J | 1 |
| Du, Y; Farlow, MR; Fontanilla, CV; Johnstone, B; Pascuzzi, RM; Wei, X; Zhao, L | 1 |
| Hisatsune, A; Isohama, Y; Katsuki, H; Kurauchi, Y; Mishima, S | 1 |
| Beltrán-Ramírez, O; Pérez, RM; Sierra-Santoyo, A; Villa-Treviño, S | 1 |
| Carvalho, LR; Castiglia, YM; Correa, RR; de Oliveira, CC; de Souza, AV; Roso, NC; Scatena, LM; Vianna, PT | 1 |
| Atar, M; Bodakcı, MN; Bozkurt, M; Bozkurt, Y; Hatipoglu, NK; Kıbrıslı, E; Penbegul, N; Sancaktutar, AA; Soylemez, H; Turkçu, G; Yavuz, C; Yuksel, H | 1 |
| Agackıran, Y; Atik, D; Delibas, N; Ginis, Z; Koylu, H; Sırmalı, M; Sırmalı, R; Solak, O; Tezel, C | 1 |
| Akoglu, M; Bostanci, EB; Duzcan, SE; Kelten, EC; Sacar, S; Simsek, NG; Teke, Z; Yenisey, C | 1 |
| Choi, J; Jeong, E; Kim, SY; Koo, JE; Lee, JY; Lim, KM; Park, ZY; Seo, YJ; Tyagi, N | 1 |
| Baffa, O; Barbosa, F; Barros Silva, R; Del-Bel, E; Ferreira, DA; Kinoshita, A; Martins, NM; Oliveira Souza, VC; Santos, AC; Santos, NA | 1 |
| Akyol, O; Güleç, M; Ozyurt, H; Sahin, S; Söğüt, S; Uz, E; Var, A | 1 |
| Ayan, I; Bora, A; Elmali, N; Germen, B; Mizrak, B; Türköz, Y | 1 |
| Bockaert, J; Briant, L; Courseau, AS; de Bock, F; Lerner-Natoli, M; Montpied, P; Niel, G; Rondouin, G | 1 |
| Arce-Popoca, E; Carrasco-Legleu, CE; Fattel-Fazenda, S; Márquez-Rosado, L; Pérez-Carreón, JI; Villa-Treviño, S | 1 |
| Akyol, O; Armutcu, F; Gurel, A; Ilhan, A; Iraz, M; Oztas, E | 1 |
| Akyol, O; Gulec, M; Iraz, M; Kalcioglu, MT; Kizilay, A; Ozerol, E; Ozturan, O | 1 |
| Altinyazar, C; Armutcu, F; Gurel, A; Hosnuter, M; Kargi, E; Unalacak, M | 1 |
| Nishioka, N; Tsuji, T; Yoshizumi, K | 1 |
| Atik, U; Cinel, L; Değirmenci, U; Kanik, A; Oz, O; Tamer, L; Vatansever, H; Yildirim, O; Yilmaz, A | 1 |
| Akyol, O; Bagci, C; Cagli, K; Cavdar, S; Cengiz, B; Dinckan, H; Gulec, M; Pence, S; Sari, I | 1 |
| Chih, CL; Huang, SS; Liao, PH; Lin, MJ; Lin, RH; Lin, SM; Liu, SM; Tsai, SK; Yang, CY | 1 |
| Erdogan, S; Fadillioglu, E; Iraz, M; Tasdemir, S | 1 |
| Ansari, MA; Elango, C; Khan, M; Singh, AK; Singh, I | 1 |
| Celik, S; Erdogan, S; Gorur, S; Hakverdi, S; Ocak, S | 1 |
| Güney, M; Karahan, N; Mungan, T; Nasir, S; Oral, B | 1 |
| Choi, I; Choi, IW; Choi, YH; Jung, WK; Kang, MS; Kim, SK; Lee, DY; Lee, SW; Park, SG; Seo, SK; Yea, SS | 1 |
| Altuğ, E; Atik, E; Avci, G; Kontas, T; Serarslan, G | 1 |
| Alhan, E; Ates, B; Ercin, C; Erdogan, S; Kaklikkaya, N; Kural Vanizor, B; Topaloglu, S; Turkyilmaz, S | 1 |
| Choi, I; Choi, IW; Choi, YH; Jeon, YJ; Jung, WK; Kim, SK; Lee, CM; Lee, DY; Lee, SW; Park, SG; Seo, SK; Yea, SS | 1 |
| Akyol, O; Ciralik, H; Ilhan, A; Koltuksuz, U; Ozen, S; Uz, E | 1 |
| Fitzpatrick, LR; Le, T; Wang, J | 1 |
3 review(s) available for caffeic acid phenethyl ester and Disease Models, Animal
| Article | Year |
|---|---|
Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting.
Topics: Amyotrophic Lateral Sclerosis; Animals; Biological Products; Disease Models, Animal; Drug Discovery; Humans; Mice; Superoxide Dismutase-1 | 2016 |
Caffeic acid phenethyl ester: its protective role against certain major eye diseases.
Topics: Animals; Bees; Caffeic Acids; Disease Models, Animal; Eye Diseases; Humans; NF-kappa B; Phenylethyl Alcohol; Propolis | 2014 |
Therapeutic Potential of Caffeic Acid Phenethyl Ester (CAPE) in Diabetes.
Topics: Animals; Antioxidants; Caffeic Acids; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Disease Progression; Humans; Oxidative Stress; Phenylethyl Alcohol; Polyphenols | 2018 |
74 other study(ies) available for caffeic acid phenethyl ester and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Investigation of the anti-inflammatory effects of caffeic acid phenethyl ester in a model of λ-Carrageenan-induced paw edema in rats.
Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Carrageenan; Disease Models, Animal; Edema; Male; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley | 2021 |
FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Protects against Oxidative Stress-Mediated Neuronal Cell Apoptosis and Scopolamine-Induced Cognitive Impairment by Activating Nrf2/HO-1 Signaling.
Topics: Alzheimer Disease; Animals; Apoptosis; Caffeic Acids; Cognitive Dysfunction; Disease Models, Animal; Glucosides; Heme Oxygenase-1; Humans; Male; Mice; Mice, Inbred Strains; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; PC12 Cells; Phenylethyl Alcohol; Rats; RNA, Small Interfering; Scopolamine; Signal Transduction | 2019 |
A biochemical and immunohistochemical study of the effects of caffeic acid phenethyl ester on alveolar bone loss and oxidative stress in diabetic rats with experimental periodontitis.
Topics: Alveolar Bone Loss; Animals; Caffeic Acids; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Oxidative Stress; Periodontitis; Phenylethyl Alcohol; Rats, Wistar; Streptozocin | 2020 |
The Impact of Propolis Factor Caffeic Acid Phenethyl-Ester on the Cerebral Vasospasm and Early Brain Damage in the Experimentally Induced Subarachnoid Hemorrhage on Rats.
Topics: Animals; CA3 Region, Hippocampal; Caffeic Acids; Disease Models, Animal; Neurons; Neuroprotective Agents; Phenylethyl Alcohol; Propolis; Rats, Wistar; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2020 |
Research on the protective effect of caffeic acid phenethyl ester on testicular damage caused by cisplatin
Topics: Animals; Antineoplastic Agents; Caffeic Acids; Cisplatin; Disease Models, Animal; Male; Phenylethyl Alcohol; Rats; Rats, Wistar; Testicular Diseases; Testis | 2020 |
Discovery of CAPE derivatives as dual EGFR and CSK inhibitors with anticancer activity in a murine model of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Binding Sites; Caffeic Acids; Carcinoma, Hepatocellular; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Liver Neoplasms; Male; Mice; Molecular Docking Simulation; Phenylethyl Alcohol; src-Family Kinases; Structure-Activity Relationship | 2021 |
The effect of caffeic acid phenethyl ester and thymoquinone on otitis media with effusion in rats.
Topics: Animals; Anti-Inflammatory Agents; Benzoquinones; Caffeic Acids; Disease Models, Animal; Eustachian Tube; Injections, Intraperitoneal; Male; Otitis Media with Effusion; Phenylethyl Alcohol; Rats; Rats, Wistar; Temporal Bone | 2017 |
Caffeic acid phenethyl ester attenuates pathological cardiac hypertrophy by regulation of MEK/ERK signaling pathway in vivo and vitro.
Topics: Animals; Blotting, Western; Caffeic Acids; Cardiomegaly; Cell Line; Disease Models, Animal; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Phenylephrine; Phenylethyl Alcohol; Polymerase Chain Reaction; Rats; Resveratrol; Smad Proteins; Stilbenes; Transforming Growth Factor beta | 2017 |
Is caffeic acid phenethyl ester more protective than doxycycline in experimental periodontitis?
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Caffeic Acids; Cytokines; Disease Models, Animal; Doxycycline; Enzyme-Linked Immunosorbent Assay; Lipid Peroxidation; Male; Oxidants; Oxidative Stress; Periodontitis; Phenylethyl Alcohol; Rats; Rats, Wistar | 2017 |
Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function.
Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Disease Models, Animal; Epithelial Cells; Female; Inflammation; Inflammation Mediators; Mice, Inbred C57BL; NF-kappa B; Phenylethyl Alcohol; Protective Agents | 2018 |
Chlorpyrifos-induced parkinsonian model in mice: Behavior, histopathology and biochemistry.
Topics: Animals; Antioxidants; Aryldialkylphosphatase; Brain; Caffeic Acids; Chlorpyrifos; Disease Models, Animal; Insecticides; Lipid Metabolism; Male; Mice; Motor Activity; N-Acetylneuraminic Acid; Neuroprotective Agents; Parkinsonian Disorders; Phenylethyl Alcohol | 2018 |
Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
Topics: Animals; Antifungal Agents; Caenorhabditis elegans; Caffeic Acids; Candida albicans; Candidiasis; Disease Models, Animal; Drug Resistance, Fungal; Drug Synergism; Drug Therapy, Combination; Fluconazole; Microbial Sensitivity Tests; Phenylethyl Alcohol | 2018 |
Anti-glioma Effects of Caffeic Acid Phenethyl Ester and Dasatinib Combination Therapy in an in vivo Rat Glioma Model.
Topics: Animals; Antineoplastic Agents; Caffeic Acids; Cell Proliferation; Dasatinib; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Glioma; Male; Molecular Structure; Phenylethyl Alcohol; Rats; Rats, Wistar; Structure-Activity Relationship; Tumor Cells, Cultured | 2018 |
Caffeic acid phenethyl ester promotes wound healing of mice pressure ulcers affecting NF-κB, NOS2 and NRF2 expression.
Topics: Animals; Caffeic Acids; Disease Models, Animal; Gene Expression Regulation; Inflammation; Lipid Peroxidation; Male; Mice; NF-E2-Related Factor 2; NF-kappa B p50 Subunit; Nitric Oxide Synthase Type II; Oxidative Stress; Phenylethyl Alcohol; Pressure Ulcer; Reactive Oxygen Species; Reperfusion Injury; Skin; Wound Healing | 2018 |
Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI.
Topics: Amino Acid Oxidoreductases; AMP-Activated Protein Kinases; Animals; Antioxidants; Behavior Rating Scale; Brain Injuries, Traumatic; Caffeic Acids; Disease Models, Animal; Drug Synergism; Dynamins; GTP Phosphohydrolases; Heme Oxygenase-1; Membrane Proteins; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Proteins; Neurons; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenylethyl Alcohol; Protein Serine-Threonine Kinases; S-Nitrosoglutathione; Superoxide Dismutase | 2018 |
Caffeic acid phenethyl ester (CAPE) reverses fibrosis caused by chronic colon inflammation in murine model of colitis.
Topics: Animals; Caffeic Acids; Colitis; Colon; Disease Models, Animal; Female; Fibrosis; Inflammation; Mice; Mice, Inbred C57BL; Phenylethyl Alcohol | 2018 |
Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis.
Topics: Albumins; Animals; Biological Availability; Caffeic Acids; Colitis; Dextran Sulfate; Disease Models, Animal; Drug Combinations; Drug Compounding; Drug Synergism; Gene Expression Regulation; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Nanoparticles; Particle Size; Phenylethyl Alcohol; Signal Transduction; Stilbenes; Transcription Factor RelA | 2019 |
Caffeic Acid Phenethyl Ester Rescues Pulmonary Arterial Hypertension through the Inhibition of AKT/ERK-Dependent PDGF/HIF-1α In Vitro and In Vivo.
Topics: Animals; Apoptosis; Caffeic Acids; Cell Line; Cell Proliferation; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Hemodynamics; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Phenylethyl Alcohol; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Rats; Signal Transduction; Vascular Remodeling | 2019 |
Caffeic acid phenethyl ester attenuates nuclear factor‑κB‑mediated inflammatory responses in Müller cells and protects against retinal ganglion cell death.
Topics: Animals; Astrocytes; Caffeic Acids; Cell Death; Cell Movement; Cell Nucleus; Cell Proliferation; Cell Survival; Chemokine CCL2; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Ependymoglial Cells; Glaucoma; Gliosis; In Situ Nick-End Labeling; Inflammation; Interleukin-6; Interleukin-8; Lipopolysaccharides; Male; NF-kappa B; Nitric Oxide Synthase Type II; Optic Nerve Injuries; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Signal Transduction; Transcription Factor Brn-3A; Tumor Necrosis Factor-alpha | 2019 |
Effect of caffeic acid phenethyl ester on intra-abdominal adhesion in rats.
Topics: Abdominal Cavity; Animals; Anti-Inflammatory Agents; Antioxidants; Caffeic Acids; Disease Models, Animal; Female; Infusions, Parenteral; Laparotomy; Phenylethyl Alcohol; Rats; Tissue Adhesions; Uterus | 2013 |
Suppression of nuclear factor erythroid 2-related factor 2 via extracellular signal-regulated kinase contributes to bleomycin-induced oxidative stress and fibrogenesis.
Topics: Animals; Antibiotics, Antineoplastic; Biomarkers; Bleomycin; Caffeic Acids; Cell Survival; Cells, Cultured; Collagen; Disease Models, Animal; Fibroblasts; Gene Silencing; Hydroxyproline; Intubation, Intratracheal; Lipid Peroxidation; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Oxidoreductases; Phenylethyl Alcohol; Pulmonary Fibrosis; Reactive Oxygen Species | 2013 |
Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Caffeic Acids; Cell Line, Tumor; Chromatography, High Pressure Liquid; Colitis; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Humans; Immunoprecipitation; NF-E2-Related Factor 2; Oxidative Stress; Phenylethyl Alcohol; Rats; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Structure-Activity Relationship | 2013 |
Caffeic acid phenethyl ester prevents apoptotic cell death in the developing rat brain after pentylenetetrazole-induced status epilepticus.
Topics: Analysis of Variance; Animals; Animals, Newborn; Apoptosis; Brain; Caffeic Acids; Caspase 3; Convulsants; Disease Models, Animal; In Situ Nick-End Labeling; Male; Neurons; Neuroprotective Agents; Pentylenetetrazole; Phenylethyl Alcohol; Rats; Rats, Wistar; Status Epilepticus | 2013 |
The effects of melatonin and caffeic acid phenethyl ester (CAPE) on fracture healing under ischemic conditions.
Topics: Animals; Antioxidants; Caffeic Acids; Disease Models, Animal; Fracture Fixation, Intramedullary; Fracture Healing; Ischemia; Male; Melatonin; Phenylethyl Alcohol; Random Allocation; Rats; Rats, Wistar; Tibial Fractures | 2014 |
The effect of caffeic acid phenethyl ester on isoproterenol-induced myocardial injury in hypertensive rats.
Topics: Animals; Antioxidants; Blood Pressure; Caffeic Acids; Disease Models, Animal; Hypertension; Injections, Intraperitoneal; Isoproterenol; Lipid Peroxidation; Myocardial Infarction; Phenylethyl Alcohol; Rats | 2014 |
Suppression of skin inflammation in keratinocytes and acute/chronic disease models by caffeic acid phenethyl ester.
Topics: Acute Disease; Animals; Caffeic Acids; Cell Line; Chronic Disease; Cyclooxygenase 2; Dermatitis, Atopic; Disease Models, Animal; Humans; Immunoglobulin E; Inflammation; Keratinocytes; Mice; Mice, Inbred Strains; NF-kappa B; Oxazolone; Phenylethyl Alcohol; Propolis; Skin; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Water Loss, Insensible | 2015 |
Caffeic acid phenethyl ester lessens disease symptoms in an experimental autoimmune uveoretinitis mouse model.
Topics: Animals; Autoimmune Diseases; Blotting, Western; Caffeic Acids; Disease Models, Animal; Eye Proteins; Flow Cytometry; Immunoglobulin G; Interferon-gamma; Interleukin-6; Lymphocyte Activation; Mice; Mice, Inbred C57BL; NF-kappa B; Phenylethyl Alcohol; Retinitis; Retinol-Binding Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; T-Lymphocytes; Tumor Necrosis Factor-alpha; Uveitis | 2015 |
Caffeic acid phenethyl ester abrogates bone resorption in a murine calvarial model of polyethylene particle-induced osteolysis.
Topics: Animals; Bone Resorption; Caffeic Acids; Disease Models, Animal; Female; Mice; Osteolysis; Phenylethyl Alcohol; Polyethylene; Skull; X-Ray Microtomography | 2015 |
Value of caffeic acid phenethyl ester pretreatment in experimental sepsis model in rats.
Topics: Animals; Caffeic Acids; Disease Models, Animal; Endothelin-1; Inflammation; Male; Malondialdehyde; Oxidative Stress; Oxygen; Phenylethyl Alcohol; Random Allocation; Rats; Rats, Wistar; Sepsis; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2015 |
The effects of caffeic acid phenethyl ester (CAPE) on bacterial translocation and inflammatory response in an experimental intestinal obstruction model in rats.
Topics: Animals; Anti-Inflammatory Agents; Bacterial Translocation; Caffeic Acids; Disease Models, Animal; Inflammation Mediators; Injections, Intraperitoneal; Intestinal Mucosa; Intestinal Obstruction; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2015 |
Caffeic Acid Phenethyl Ester inhibit Hepatic Fibrosis by Nitric Oxide Synthase and Cystathionine Gamma-Lyase in Rats.
Topics: Animals; Caffeic Acids; Cystathionine gamma-Lyase; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Hydrogen Sulfide; Immunohistochemistry; Liver; Liver Cirrhosis; Male; Nitric Oxide Synthase Type II; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley | 2015 |
Effect of caffeic acid phenethyl ester on oxidant and anti-oxidant status of liver and serum in a rat model with acute methanol intoxication.
Topics: Animals; Antioxidants; Caffeic Acids; Disease Models, Animal; Ethanol; Liver; Male; Methanol; Methotrexate; Oxidants; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley | 2017 |
Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout.
Topics: Administration, Oral; Animals; Biomarkers; Caffeic Acids; CARD Signaling Adaptor Proteins; Disease Models, Animal; Gout; Inflammasomes; Liquid Crystals; Macrophages; Mice; Models, Molecular; Molecular Conformation; NLR Family, Pyrin Domain-Containing 3 Protein; Phenylethyl Alcohol; Protein Binding; Uric Acid | 2016 |
The effects of pollen, propolis, and caffeic acid phenethyl ester on tyrosine hydroxylase activity and total RNA levels in hypertensive rats caused by nitric oxide synthase inhibition: experimental, docking and molecular dynamic studies.
Topics: Adrenal Medulla; Animals; Caffeic Acids; Catalytic Domain; Catecholamines; Disease Models, Animal; Heart; Humans; Hypertension; Hypothalamus; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phenylethyl Alcohol; Pollen; Propolis; Rats; Tyrosine 3-Monooxygenase | 2018 |
Zinc deficiency induces vascular pro-inflammatory parameters associated with NF-kappaB and PPAR signaling.
Topics: Animals; Atherosclerosis; Caffeic Acids; Cell Adhesion; Cells, Cultured; Cyclooxygenase 2; Disease Models, Animal; Endothelial Cells; Gene Expression Regulation; Inflammation; Male; Mice; Monocytes; NF-kappa B; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Phenylethyl Alcohol; Receptors, LDL; Rosiglitazone; Thiazolidinediones; Zinc | 2008 |
Protective role of caffeic acid phenethyl ester and erdosteine on activities of purine-catabolizing enzymes and level of nitric oxide in red blood cells of isoniazid-administered rats.
Topics: Adenosine Deaminase; Administration, Oral; Animals; Antioxidants; Antitubercular Agents; Caffeic Acids; Disease Models, Animal; Drinking; Drug Therapy, Combination; Erythrocytes; Injections, Intraperitoneal; Isoniazid; Male; Nitric Oxide; Oxidative Stress; Phenylethyl Alcohol; Purines; Rats; Rats, Wistar; Thioglycolates; Thiophenes; Xanthine Oxidase | 2008 |
Therapeutic effect of caffeic acid phenethyl ester on cerulein-induced acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Caffeic Acids; Ceruletide; Cytotoxins; Disease Models, Animal; Edema; Leukocyte Count; Lipase; Male; Pancreas; Pancreatitis; Phenylethyl Alcohol; Rats; Rats, Wistar; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Protective effect of caffeic acid phenethyl ester on cyclosporine A-induced nephrotoxicity in rats.
Topics: Animals; Antioxidants; Caffeic Acids; Cyclosporine; Disease Models, Animal; Female; Immunosuppressive Agents; Kidney; Kidney Diseases; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2009 |
The effects of caffeic acid phenethyl ester and melatonin on age-related vascular remodeling and cardiac damage.
Topics: Aging; Animals; Antioxidants; Aorta; Caffeic Acids; Catalase; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Assays; Glutathione; Heart; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Mitochondria; Myocardium; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2011 |
Caffeic acid phenethyl ester protects against oxidative stress-related renal dysfunction in rats treated with cyclosporin A.
Topics: Acute Kidney Injury; Animals; Antioxidants; Blood Urea Nitrogen; Body Weight; Caffeic Acids; Creatinine; Cyclosporine; Disease Models, Animal; Drug Evaluation, Preclinical; Feeding Behavior; Glutathione; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Malondialdehyde; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar; Superoxide Dismutase | 2011 |
Protective effects of caffeic acid phenethyl ester (CAPE) on intestinal damage in necrotizing enterocolitis.
Topics: Administration, Oral; Animals; Animals, Newborn; Apoptosis; Caffeic Acids; Caspase 9; Cell Count; Disease Models, Animal; Enterocolitis, Necrotizing; Ileum; Immunohistochemistry; In Situ Nick-End Labeling; NF-kappa B; Oxidative Stress; Peroxidase; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Treatment Outcome; Xanthine Oxidase | 2011 |
Caffeic Acid phenethyl ester protects blood-brain barrier integrity and reduces contusion volume in rodent models of traumatic brain injury.
Topics: Animals; Blood-Brain Barrier; Brain Injuries; Caffeic Acids; Disease Models, Animal; Fluorescent Antibody Technique; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Recovery of Function | 2012 |
Caffeic acid phenethyl ester extends survival of a mouse model of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeic Acids; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Transgenic; Neuroprotective Agents; Phenylethyl Alcohol; Survival Rate; Treatment Outcome | 2012 |
Caffeic acid phenethyl ester protects nigral dopaminergic neurons via dual mechanisms involving haem oxygenase-1 and brain-derived neurotrophic factor.
Topics: Animals; Blotting, Western; Brain-Derived Neurotrophic Factor; Caffeic Acids; Disease Models, Animal; Dopaminergic Neurons; Enzyme Induction; Heme Oxygenase-1; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitric Oxide; Parkinsonian Disorders; Phenylethyl Alcohol; Rats; Rats, Wistar; Substantia Nigra | 2012 |
Cancer prevention mediated by caffeic acid phenethyl ester involves cyp2b1/2 modulation in hepatocarcinogenesis.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Benzoflavones; Caffeic Acids; Carcinogenicity Tests; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2B1; Cytochromes; Diethylnitrosamine; Disease Models, Animal; Liver Neoplasms, Experimental; Male; Phenylethyl Alcohol; Proadifen; Rats; Rats, Inbred F344; Steroid Hydroxylases | 2012 |
Caffeic acid phenethyl ester effects in the kidney during ischemia and reperfusion in rats anesthetized with isoflurane.
Topics: Anesthetics, Inhalation; Animals; Biomarkers; Caffeic Acids; Creatinine; Disease Models, Animal; Isoflurane; Kidney; Male; Necrosis; Phenylethyl Alcohol; Rats; Rats, Wistar; Reperfusion Injury; Time Factors | 2012 |
Caffeic acid phenethyl ester protects kidneys against acetylsalicylic acid toxicity in rats.
Topics: Acute Kidney Injury; Animals; Aspirin; Caffeic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Kidney; NF-kappa B; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar | 2012 |
Comparative analysis of the protective effects of caffeic acid phenethyl ester (CAPE) on pulmonary contusion lung oxidative stress and serum copper and zinc levels in experimental rat model.
Topics: Analysis of Variance; Animals; Blood Gas Analysis; Caffeic Acids; Catalase; Contusions; Copper; Disease Models, Animal; Humans; Lung; Male; Malondialdehyde; Oxidative Stress; Phenylethyl Alcohol; Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Zinc | 2013 |
Effects of caffeic acid phenethyl ester on anastomotic healing in secondary peritonitis.
Topics: Anastomosis, Surgical; Animals; Caffeic Acids; Colon; Disease Models, Animal; Glutathione; Hydroxyproline; Male; Malondialdehyde; Peritonitis; Peroxidase; Phenylethyl Alcohol; Pressure; Rats; Rats, Wistar; Stress, Mechanical; Superoxide Dismutase; Wound Healing | 2012 |
Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.
Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Cell Line; Chromatography, Gas; Disease Models, Animal; Gene Expression Regulation; HEK293 Cells; Humans; Inflammation; Interferon Regulatory Factor-3; Lipopolysaccharides; Lymphocyte Antigen 96; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Phenylethyl Alcohol; Signal Transduction; Tandem Mass Spectrometry; Toll-Like Receptor 4 | 2013 |
Caffeic acid phenethyl ester protects against the dopaminergic neuronal loss induced by 6-hydroxydopamine in rats.
Topics: Adrenergic Agents; Animals; Antioxidants; Caffeic Acids; Cell Death; Disease Models, Animal; Dopaminergic Neurons; Free Radical Scavengers; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phenylethyl Alcohol; Rats; Rats, Wistar | 2013 |
The protective role of caffeic acid phenethyl ester (CAPE) on testicular tissue after testicular torsion and detorsion.
Topics: Animals; Caffeic Acids; Catalase; Disease Models, Animal; Glutathione Peroxidase; Male; Peroxidase; Phenylethyl Alcohol; Protective Agents; Rats; Reperfusion Injury; Spermatic Cord Torsion; Superoxide Dismutase; Testis; Thiobarbituric Acid Reactive Substances | 2002 |
Effect of caffeic acid phenethyl ester on cartilage in experimental osteoarthritis.
Topics: Animals; Anterior Cruciate Ligament; Anterior Cruciate Ligament Injuries; Caffeic Acids; Cartilage, Articular; Disease Models, Animal; Disease Progression; Extracellular Matrix; Hindlimb; Injections, Intra-Articular; NF-kappa B; Osteoarthritis, Knee; Phenylethyl Alcohol; Proteoglycans; Rabbits | 2002 |
Caffeic acid phenethyl ester (CAPE) prevents inflammatory stress in organotypic hippocampal slice cultures.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Antioxidants; Caenorhabditis elegans Proteins; Caffeic Acids; Cell Nucleus; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electrophoretic Mobility Shift Assay; Hippocampus; Immunohistochemistry; Inflammation; Interferon-gamma; Lipopolysaccharides; NF-kappa B; Nitrites; Organ Culture Techniques; Phenylethyl Alcohol; Rats; Rats, Wistar; Stress, Physiological; Tumor Necrosis Factor-alpha | 2003 |
Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay.
Topics: Animals; Blotting, Western; Caffeic Acids; Carcinoma, Hepatocellular; Cell Nucleus; Disease Models, Animal; Disease Progression; gamma-Glutamyltransferase; Gene Expression Regulation; Glutathione S-Transferase pi; Glutathione Transferase; Humans; I-kappa B Proteins; Isoenzymes; Liver Neoplasms, Experimental; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Phenylethyl Alcohol; Precancerous Conditions; Protein Transport; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2004 |
Protective effects of caffeic acid phenethyl ester against experimental allergic encephalomyelitis-induced oxidative stress in rats.
Topics: Animals; Biomarkers; Brain; Caffeic Acids; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Oxidative Stress; Phenylethyl Alcohol; Protective Agents; Rats; Rats, Wistar; Spinal Cord | 2004 |
Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats.
Topics: Analysis of Variance; Animals; Caffeic Acids; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Hearing Loss, Sensorineural; Otoacoustic Emissions, Spontaneous; Phenylethyl Alcohol; Probability; Random Allocation; Rats; Rats, Wistar; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric | 2004 |
Caffeic acid phenethyl ester improves oxidative organ damage in rat model of thermal trauma.
Topics: Animals; Burns; Caffeic Acids; Disease Models, Animal; Injections, Intraperitoneal; Kidney Diseases; Lung Diseases; Male; Malondialdehyde; Multiple Organ Failure; Oxidoreductases; Phenylethyl Alcohol; Rats; Rats, Wistar; Treatment Outcome | 2004 |
[Xanthine oxidase inhibitory activity and hypouricemia effect of propolis in rats].
Topics: Animals; Anti-Infective Agents; Brazil; Caffeic Acids; China; Coumaric Acids; Disease Models, Animal; Flavonoids; Gout; Hyperuricemia; Male; Oxonic Acid; Phenylethyl Alcohol; Phenylpropionates; Propionates; Propolis; Rats; Rats, Sprague-Dawley; Uric Acid; Xanthine Oxidase | 2005 |
Effects of caffeic acid phenethyl ester on endotoxin-induced uveitis in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aqueous Humor; Caffeic Acids; Ciliary Body; Disease Models, Animal; Eye Proteins; Injections, Intraperitoneal; Iris; Lipopolysaccharides; Male; Peroxidase; Phenylethyl Alcohol; Rats; Rats, Wistar; Salmonella typhimurium; Uveitis | 2005 |
In vivo effects of caffeic acid phenethyl ester on myocardial ischemia-reperfusion injury and apoptotic changes in rats.
Topics: Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; Caffeic Acids; Cell Count; Coronary Disease; Creatine Kinase; Disease Models, Animal; Glutathione; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Myocardial Reperfusion Injury; Nitric Oxide; Phenylethyl Alcohol; Rats; Rats, Wistar | 2005 |
Caffeic acid phenethyl ester ameliorates cerebral infarction in rats subjected to focal cerebral ischemia.
Topics: Animals; Antioxidants; Blood Flow Velocity; Brain; Brain Ischemia; Caffeic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Nitric Oxide; Phenylethyl Alcohol; Rats; Rats, Long-Evans; Reperfusion Injury | 2006 |
Role of vagal activity on bradicardic and hypotensive effects of caffeic acid phenethyl ester (CAPE).
Topics: Animals; Antihypertensive Agents; Atropine; Blood Pressure; Bradycardia; Caffeic Acids; Disease Models, Animal; Male; Muscarinic Antagonists; Parasympathetic Nervous System; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Vagotomy; Vagus Nerve | 2005 |
Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Caffeic Acids; Cerebrovascular Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Encephalitis; Inflammation Mediators; Ischemic Attack, Transient; Male; Neuroprotective Agents; NF-kappa B; Nitric Oxide; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Treatment Outcome | 2007 |
Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Blood Urea Nitrogen; Caffeic Acids; Catalase; Disease Models, Animal; Drinking; Drug Combinations; Injections, Intramuscular; Injections, Intraperitoneal; Kidney; Kidney Diseases; Male; Phenylethyl Alcohol; Rats; Rats, Wistar; Vancomycin; Vitamin E; Water Supply | 2007 |
Effect of caffeic acid phenethyl ester on the regression of endometrial explants in an experimental rat model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Caffeic Acids; Catalase; Cyclooxygenase 2; Disease Models, Animal; Endometriosis; Endometrium; Female; Lipid Peroxidation; Malondialdehyde; Phenylethyl Alcohol; Rats; Rats, Wistar; Statistics, Nonparametric; Superoxide Dismutase; Transplantation, Autologous; Uterus | 2007 |
Evaluation of anti-allergic properties of caffeic acid phenethyl ester in a murine model of systemic anaphylaxis.
Topics: Anaphylaxis; Animals; Anti-Allergic Agents; Caffeic Acids; Disease Models, Animal; Female; Histamine Release; Immunoglobulin E; Mice; Mice, Inbred ICR; NF-kappa B; Ovalbumin; Phenylethyl Alcohol; Tumor Necrosis Factor-alpha | 2008 |
Caffeic acid phenethyl ester accelerates cutaneous wound healing in a rat model and decreases oxidative stress.
Topics: Animals; Antioxidants; Caffeic Acids; Disease Models, Animal; Drug Evaluation, Preclinical; Free Radical Scavengers; Glutathione; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Phenylethyl Alcohol; Rats; Rats, Wistar; Reactive Oxygen Species; Skin; Superoxide Dismutase; Wound Healing | 2007 |
Effects of caffeic acid phenethyl ester on pancreatitis in rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Bacterial Translocation; Bronchoalveolar Lavage Fluid; Caffeic Acids; Detergents; Disease Models, Animal; Glycodeoxycholic Acid; L-Lactate Dehydrogenase; Lung; Male; Malondialdehyde; Pancreas; Pancreatitis, Acute Necrotizing; Peroxidase; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley | 2008 |
Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Blotting, Western; Bronchoalveolar Lavage Fluid; Caffeic Acids; Cell Count; Cytokines; Disease Models, Animal; Eosinophils; Female; Immunoglobulin E; Lung; Mice; Mice, Inbred BALB C; NF-kappa B; Ovalbumin; Peroxides; Phenylethyl Alcohol; Respiratory Hypersensitivity | 2008 |
The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits.
Topics: Animals; Antioxidants; Caffeic Acids; Catalase; Disease Models, Animal; Drug Therapy, Combination; Injections, Intraperitoneal; Malondialdehyde; Methylprednisolone; Movement; Neuroprotective Agents; NF-kappa B; Phenylethyl Alcohol; Rabbits; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia; Superoxide Dismutase | 1999 |
Caffeic acid phenethyl ester, an inhibitor of nuclear factor-kappaB, attenuates bacterial peptidoglycan polysaccharide-induced colitis in rats.
Topics: Animals; Apoptosis; Arthritis; Caffeic Acids; Cells, Cultured; Colitis; Colon; Cytokines; Disease Models, Animal; Female; Humans; NF-kappa B; Peptidoglycan; Phenylethyl Alcohol; Rats; Rats, Inbred Lew | 2001 |